TRAIL and IFNα act synergistically to induce renal cell carcinoma apoptosis

INTRODUCTION: Despite modern targeted therapy, metastatic renal cell carcinoma (RCC) remains a deadly disease. Interferon alpha (IFNα) is currently used to treat this condition, mainly in combination with the targeted anti-VEGF antibody, bevacizumab. Apo2 ligand/Tumor necrosis factor related apoptos...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Clark, Peter E., Polosukhina, Dina A., Gyabaah, Kenneth, Moses, Harold L., Thorburn, Andrew, Zent, Roy
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2010
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2963111/
https://ncbi.nlm.nih.gov/pubmed/20663526
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.juro.2010.04.064
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia